Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2022

Open Access 01-12-2022 | Coronary Heart Disease | Research

Associations between comorbidities and annual incidence plus frequency of asthma exacerbation hospitalisation during the past year: data from CARN study

Authors: Wenqiao Wang, Jiangtao Lin, Xin Zhou, Changzheng Wang, Mao Huang, Shaoxi Cai, Ping Chen, Qichang Lin, Jianying Zhou, Yuhai Gu, Yadong Yuan, Dejun Sun, Xiaohong Yang, Lan Yang, Jianmin Huo, Zhuochang Chen, Ping Jiang, Jie Zhang, Xianwei Ye, Huiguo Liu, Huaping Tang, Rongyu Liu, Chuntao Liu, Wei Zhang, Chengping Hu, Yiqiang Chen, Xiaoju Liu, Luming Dai, Wei Zhou, Yijiang Huang, Jianying Xu

Published in: BMC Pulmonary Medicine | Issue 1/2022

Login to get access

Abstract

Purpose

While asthma comorbidities are associated with higher health care utilisation, lower quality of life and poorer asthma control, the impact of asthma comorbidities on hospitalisation for asthma exacerbation (H-AX) remains less recognised. We aim to analyse the impact of asthma comorbidities on H-AX.

Methods

Based on a national survey on asthma control and disease perception (CARN 2015 study), we analysed the impact of comorbidities on annual incidence and frequency of H-AX in China. Information on demographic characteristics, asthma comorbidities and annual incidence and frequency of H-AX were presented in this study.

Results

Among 3875 ambulatory asthma patients, 75.9% (2941/3875) had comorbidities, and 26.4% (1017/3858) experienced H-AX during past year. After adjusting for confounding factors such as demographic data, smoking status and asthma control, COPD [OR = 2.189, 95% CI (1.673, 2.863)] and coronary heart disease [OR = 1.387, 95% CI (1.032, 1.864)] were associated with higher annual incidence, while allergic rhinitis [OR = 0.692, 95% CI (0.588, 0.815)] was associated with lower annual incidence, of H-AX. In terms of frequency, allergic rhinitis [OR = 1.630, 95% CI (1.214, 2.187)], COPD [OR = 1.472, 95% CI (1.021, 2.122)] and anxiety [OR = 2.609, 95% CI (1.051, 6.477)] showed statistically significant correlation with frequent H-AX.

Conclusions

COPD and coronary heart disease were associated with higher annual incidence, while allergic rhinitis was associated with lower annual incidence of H-AX. Allergic rhinitis, COPD and anxiety were associated with frequent H-AX. Comorbidities may have an important role in the risk and frequency of annual hospitalisations due to asthma exacerbation. The goal of asthma control should rely on a multi-disciplinary treatment protocol.
Literature
2.
go back to reference Lin J, Xing B, Tang H, Yang L, Yuan Y, Gu Y, et al. Hospitalization due to asthma exacerbation: a China Asthma Research Network (CARN) retrospective study in 29 provinces across Mainland China. Allergy Asthma Immunol Res. 2020;12(3):485–95.CrossRef Lin J, Xing B, Tang H, Yang L, Yuan Y, Gu Y, et al. Hospitalization due to asthma exacerbation: a China Asthma Research Network (CARN) retrospective study in 29 provinces across Mainland China. Allergy Asthma Immunol Res. 2020;12(3):485–95.CrossRef
3.
go back to reference Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125:1178–87.CrossRef Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125:1178–87.CrossRef
4.
go back to reference Erbas B, Jazayeri M, Lambert KA, Katelaris CH, Dharmage SC. Outdoor pollen is a trigger of child and adolescent asthma emergency department presentations: a systematic review and meta-analysis. Allergy. 2018;73:1632–41.CrossRef Erbas B, Jazayeri M, Lambert KA, Katelaris CH, Dharmage SC. Outdoor pollen is a trigger of child and adolescent asthma emergency department presentations: a systematic review and meta-analysis. Allergy. 2018;73:1632–41.CrossRef
5.
go back to reference Anto JM, Sunyer J, Reed CE, Sabria J, Martinez F, Morell F, et al. Preventing asthma epidemics due to soybeans by dust-control measures. N Engl J Med. 1993;329:1760–3.CrossRef Anto JM, Sunyer J, Reed CE, Sabria J, Martinez F, Morell F, et al. Preventing asthma epidemics due to soybeans by dust-control measures. N Engl J Med. 1993;329:1760–3.CrossRef
6.
go back to reference Burks AW, Tang M, Sicherer S, Muraro A, Sampson HA. ICON: food allergy. J Allergy Clin Immunol. 2012;129:906–20.CrossRef Burks AW, Tang M, Sicherer S, Muraro A, Sampson HA. ICON: food allergy. J Allergy Clin Immunol. 2012;129:906–20.CrossRef
7.
go back to reference Mazenq J, Dubus JC, Gaudart J, Charpin D, Viudes G, Noel G. City housing atmospheric pollutant impact on emergency visit for asthma: a classification and regression tree approach. Respir Med. 2017;132:1–8.CrossRef Mazenq J, Dubus JC, Gaudart J, Charpin D, Viudes G, Noel G. City housing atmospheric pollutant impact on emergency visit for asthma: a classification and regression tree approach. Respir Med. 2017;132:1–8.CrossRef
8.
go back to reference Orellano P, Quaranta N, Reynoso J, Balbi B, Vasquez J. Effect of outdoor air pollution on asthma exacerbations in children and adults: Systematic review and multilevel meta-analysis. PLoS ONE. 2017;12: e0174050.CrossRef Orellano P, Quaranta N, Reynoso J, Balbi B, Vasquez J. Effect of outdoor air pollution on asthma exacerbations in children and adults: Systematic review and multilevel meta-analysis. PLoS ONE. 2017;12: e0174050.CrossRef
9.
go back to reference Sousa SI, Ferraz C, Alvim-Ferraz MC, Vaz LG, Marques AJ, Martins FG. Indoor air pollution on nurseries and primary schools: impact on childhood asthma–study protocol. BMC Public Health. 2012;13(12):435.CrossRef Sousa SI, Ferraz C, Alvim-Ferraz MC, Vaz LG, Marques AJ, Martins FG. Indoor air pollution on nurseries and primary schools: impact on childhood asthma–study protocol. BMC Public Health. 2012;13(12):435.CrossRef
10.
go back to reference Ndwiga T, Kei RM, Jepngetich H, Korrir K. Assessment of health effects related to the use of biomass fuel and indoor air pollution in kapkokwon sub-location, bomet country, kenya. Open J Air Pollut. 2014;3(3):9. Ndwiga T, Kei RM, Jepngetich H, Korrir K. Assessment of health effects related to the use of biomass fuel and indoor air pollution in kapkokwon sub-location, bomet country, kenya. Open J Air Pollut. 2014;3(3):9.
12.
go back to reference Kim JL, Henneberger PK, Lohman S, Olin AC, Dahlman-Höglund A, Andersson E, et al. Impact of occupational exposures on exacerbation of asthma: a population-based asthma cohort study. BMC Pulm Med. 2016;16(1):148.CrossRef Kim JL, Henneberger PK, Lohman S, Olin AC, Dahlman-Höglund A, Andersson E, et al. Impact of occupational exposures on exacerbation of asthma: a population-based asthma cohort study. BMC Pulm Med. 2016;16(1):148.CrossRef
13.
go back to reference Pike KC, Akhbari M, Kneale D, Harris KM. Interventions for autumn exacerbations of asthma in children. Cochrane Database Syst Rev. 2018;3:Cd012393.PubMed Pike KC, Akhbari M, Kneale D, Harris KM. Interventions for autumn exacerbations of asthma in children. Cochrane Database Syst Rev. 2018;3:Cd012393.PubMed
14.
go back to reference Williams LK, Peterson EL, Wells K, Ahmedani B, Kumar R, Burchard EG. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011;128(1185–91): e2. Williams LK, Peterson EL, Wells K, Ahmedani B, Kumar R, Burchard EG. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011;128(1185–91): e2.
15.
go back to reference Haselkorn T, Fish JE, Zeiger RS, Szefler SJ, Miller DP, Chipps BE. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol. 2009;124:895-902.e1-4.CrossRef Haselkorn T, Fish JE, Zeiger RS, Szefler SJ, Miller DP, Chipps BE. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol. 2009;124:895-902.e1-4.CrossRef
16.
go back to reference Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128:2099e107.CrossRef Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128:2099e107.CrossRef
17.
go back to reference Wijnhoven HA, Kriegsman DM, Hesselink AE, Haan MD, Schellevis FG. The influence of co-morbidity on health-related quality of life in asthma and COPD patients. Respir Med. 2003;97:468e75.CrossRef Wijnhoven HA, Kriegsman DM, Hesselink AE, Haan MD, Schellevis FG. The influence of co-morbidity on health-related quality of life in asthma and COPD patients. Respir Med. 2003;97:468e75.CrossRef
18.
go back to reference Lehrer PM, Karavidas MK, Lu SE, Feldman J, Kranitz L, Abraham S, et al. Psychological treatment of comorbid asthma and panic disorder: a pilot study. J Anxiety Disord. 2008;22:671e83.CrossRef Lehrer PM, Karavidas MK, Lu SE, Feldman J, Kranitz L, Abraham S, et al. Psychological treatment of comorbid asthma and panic disorder: a pilot study. J Anxiety Disord. 2008;22:671e83.CrossRef
19.
go back to reference Deshmukh VM, Toelle BG, Usherwood T, O’Grady B, Jenkins C. The association of comorbid anxiety and depression with asthma-related quality of life and symptom perception in adults. Respirology. 2008;13(5):695–702.CrossRef Deshmukh VM, Toelle BG, Usherwood T, O’Grady B, Jenkins C. The association of comorbid anxiety and depression with asthma-related quality of life and symptom perception in adults. Respirology. 2008;13(5):695–702.CrossRef
20.
go back to reference Lin J, Wang W, Zhou X, Wang C, Huang M, Cai S, et al. The level of asthma control in China from a national asthma control survey. Chin J Tubere Respir Dis. 2017;40(7):494–8. Lin J, Wang W, Zhou X, Wang C, Huang M, Cai S, et al. The level of asthma control in China from a national asthma control survey. Chin J Tubere Respir Dis. 2017;40(7):494–8.
21.
go back to reference Ten BA, Grootendorst DC, Schmidt JT, Bruine TD, Buchem MA, Sterk PJ, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol. 2002;109(4):621–6.CrossRef Ten BA, Grootendorst DC, Schmidt JT, Bruine TD, Buchem MA, Sterk PJ, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol. 2002;109(4):621–6.CrossRef
22.
go back to reference Bachert C, Zhang N. Chronic rhinosinusitis and asthma: novel understanding of the role of IgE ‘above atopy.’ J Intern Med. 2012;272(2):133–43.CrossRef Bachert C, Zhang N. Chronic rhinosinusitis and asthma: novel understanding of the role of IgE ‘above atopy.’ J Intern Med. 2012;272(2):133–43.CrossRef
23.
go back to reference Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy. 2010;35(3):282–7.CrossRef Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy. 2010;35(3):282–7.CrossRef
24.
go back to reference Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics. 2005;115(1):129–34.CrossRef Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics. 2005;115(1):129–34.CrossRef
25.
go back to reference Bousquet J, Gaugris S, Kocevar VS, Zhang Q, Yin DD, Polos PG, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clin Exp Allergy. 2005;35(6):723–7.CrossRef Bousquet J, Gaugris S, Kocevar VS, Zhang Q, Yin DD, Polos PG, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clin Exp Allergy. 2005;35(6):723–7.CrossRef
26.
go back to reference López-Chacón M, Mullol J, Pujols L. Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis. Curr Allergy Asthma Rep. 2015;15(5):19.CrossRef López-Chacón M, Mullol J, Pujols L. Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis. Curr Allergy Asthma Rep. 2015;15(5):19.CrossRef
28.
go back to reference Hsu J, Chen J, Mirabelli MC. Asthma morbidity, comorbidities, and modifiable factors among older adults. J Allergy Clin Immunol Pract. 2018;6:236-43.e7.CrossRef Hsu J, Chen J, Mirabelli MC. Asthma morbidity, comorbidities, and modifiable factors among older adults. J Allergy Clin Immunol Pract. 2018;6:236-43.e7.CrossRef
29.
go back to reference Fitzpatrick S, Joks R, Silverberg JI. Obesity is associated with increased asthma severity and exacerbations, and increased serum immunoglobulin E in inner-city adults. Clin Exp Allergy. 2012;42(5):747–59.CrossRef Fitzpatrick S, Joks R, Silverberg JI. Obesity is associated with increased asthma severity and exacerbations, and increased serum immunoglobulin E in inner-city adults. Clin Exp Allergy. 2012;42(5):747–59.CrossRef
30.
go back to reference Song Y, Klevak A, Manson J, Buring J, Liu S. Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women’s Health Study. Diabetes Res Clin Pract. 2010;90(3):365–71.CrossRef Song Y, Klevak A, Manson J, Buring J, Liu S. Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women’s Health Study. Diabetes Res Clin Pract. 2010;90(3):365–71.CrossRef
31.
go back to reference Perez MK, Piedimonte G. Metabolic asthma: is there a link between obesity, diabetes, and asthma? Immunol Allergy Clin N Am. 2014;34(4):777–84.CrossRef Perez MK, Piedimonte G. Metabolic asthma: is there a link between obesity, diabetes, and asthma? Immunol Allergy Clin N Am. 2014;34(4):777–84.CrossRef
32.
go back to reference Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253:574–81.CrossRef Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253:574–81.CrossRef
33.
go back to reference Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women’s Heart and Health Study. Diabetologia. 2004;47:195–203.CrossRef Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women’s Heart and Health Study. Diabetologia. 2004;47:195–203.CrossRef
34.
go back to reference McKeever TM, Weston PJ, Hubbard R, Fogarty A. Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2005;161:546–56.CrossRef McKeever TM, Weston PJ, Hubbard R, Fogarty A. Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2005;161:546–56.CrossRef
35.
go back to reference Barrecheguren M, Pinto L, Mostafavi-Pour-Manshadi SM, Tan W, Bourbeau J, et al. Identification and definition of asthma-COPD overlap: the CanCOLD study. Respirology. 2020;25:836–49.CrossRef Barrecheguren M, Pinto L, Mostafavi-Pour-Manshadi SM, Tan W, Bourbeau J, et al. Identification and definition of asthma-COPD overlap: the CanCOLD study. Respirology. 2020;25:836–49.CrossRef
36.
go back to reference Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS ONE. 2015;10: e0136065.CrossRef Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS ONE. 2015;10: e0136065.CrossRef
37.
go back to reference Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64:728–35.CrossRef Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64:728–35.CrossRef
38.
go back to reference Andersen H, Lampela P, Nevanlinna A, Saynajakangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J. 2013;7:342–6.CrossRef Andersen H, Lampela P, Nevanlinna A, Saynajakangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J. 2013;7:342–6.CrossRef
39.
go back to reference Mao B, Yang JW, Lu HW, Xu JF. Asthma and bronchiectasis exacerbation. Eur Respir J. 2016;47:1680.CrossRef Mao B, Yang JW, Lu HW, Xu JF. Asthma and bronchiectasis exacerbation. Eur Respir J. 2016;47:1680.CrossRef
40.
go back to reference Kang HR, Choi GS, Park SJ, Song YK, Kim JM, Ha J, et al. The effects of bronchiectasis on asthma exacerbation. Tuberc Respir Dis. 2014;77(6):279.CrossRef Kang HR, Choi GS, Park SJ, Song YK, Kim JM, Ha J, et al. The effects of bronchiectasis on asthma exacerbation. Tuberc Respir Dis. 2014;77(6):279.CrossRef
41.
go back to reference Harding SM, Richter JE. The role of gastroesophageal reflux in chronic cough and asthma. Chest. 1997;111:1389–402.CrossRef Harding SM, Richter JE. The role of gastroesophageal reflux in chronic cough and asthma. Chest. 1997;111:1389–402.CrossRef
42.
go back to reference Rameschandra S, Acharya V, Kunal, Vishwanath T, Acharya P. Prevalence and spectrum of gastro esophageal reflux disease in bronchial asthma. J Clin Diagn Res. 2015;9(10):11–4. Rameschandra S, Acharya V, Kunal, Vishwanath T, Acharya P. Prevalence and spectrum of gastro esophageal reflux disease in bronchial asthma. J Clin Diagn Res. 2015;9(10):11–4.
43.
go back to reference Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol. 2007;119(2):405–13.CrossRef Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol. 2007;119(2):405–13.CrossRef
Metadata
Title
Associations between comorbidities and annual incidence plus frequency of asthma exacerbation hospitalisation during the past year: data from CARN study
Authors
Wenqiao Wang
Jiangtao Lin
Xin Zhou
Changzheng Wang
Mao Huang
Shaoxi Cai
Ping Chen
Qichang Lin
Jianying Zhou
Yuhai Gu
Yadong Yuan
Dejun Sun
Xiaohong Yang
Lan Yang
Jianmin Huo
Zhuochang Chen
Ping Jiang
Jie Zhang
Xianwei Ye
Huiguo Liu
Huaping Tang
Rongyu Liu
Chuntao Liu
Wei Zhang
Chengping Hu
Yiqiang Chen
Xiaoju Liu
Luming Dai
Wei Zhou
Yijiang Huang
Jianying Xu
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2022
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-022-02038-3

Other articles of this Issue 1/2022

BMC Pulmonary Medicine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine